All In MedTech

Device Trial Radar · NCT02310100

TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study

Last checked: Nov 20, 2026Latest source record: Oct 12, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

178

Actual

Start

Jan 21, 2015

Primary completion

Feb 2017

Study completion Sep 17, 2021

Sponsor

Lead sponsor
Abbott Medical DevicesPublic (ABT)
Sponsor type
Industry
First posted
Dec 5, 2014

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A prospective, multicenter, interventional study to collect confirmatory evidence on the safety and effectiveness of the TactiCath® percutaneous ablation catheter in the post approval setting for the treatment of symptomatic paroxysmal atrial fibrillation using contact force assisted irrigated radiofrequency ablation.

Conditions

  • Paroxysmal Atrial Fibrillation

Interventions

  • TactiCath Quartz treatmentDevice

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Participants Free From Recurrent, Symptomatic Paroxysmal Atrial Fibrillation (PAF), Atrial Flutter (AFL), and Atrial Tachycardia (AT)Time frame: 12 Months post ablation
  2. Number of Participants Experiencing a Device or Procedure-related Serious Adverse EventTime frame: 7 days

Locations

20 sites in 1 country. Site status is shown where the registry gives one.

  • Glendale Memorial Hospital and Health Center

    Glendale, California

  • Regional Cardiology Associates

    Sacramento, California

  • Emory University Hospital

    Atlanta, Georgia

17 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.